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The term “cardiovascular disease” (CVD) refers toa specific and particularly devastating group of
diseases that affect the heart and its blood vessels,
including coronary heart disease (CHD) and heart
failure (HF) (Public Health Agency of Canada). It
is the second leading cause of deaths in Canada,
and claimed over 51,000 lives in 2016 (Statistics
Canada). However, not all ethnic groups are propor-
tionately represented among those with CVD. South
Asians (i.e. people from India, Pakistan, Nepal, Sri
Lanka, and Bangladesh) have both higher prevalence
and higher incidence than other groups (Rana et al.
E189).
Navdeep Singh Bedi is an active father of two
young children. He does not drink or smoke, is not
overweight, and has no apparent family history of
CVD. For the average person, these factors would
indicate no particular risk of a myocardial infarc-
tion (MI) or CHD. Yet in 2009, at age 35, Bedi
underwent a double bypass surgery to clear block-
age from his coronary arteries. Despite presenting
symptoms like shortness of breath, physicians only
suspected CHD after multiple visits. Only Bedi’s
South Asian (SA) ancestry could have tipped them
off earlier (Weeks). What is alarming is that Bedi is
not alone. There have been numerous cases world-
wide that sound eerily similar (Razak and Fernando;
O’Connor). In each case doctors were ignorant of
the SA CVD risk profile and continuously failed to
recognize the signs of CHD until it was almost too
late. It is important to clarify that, as Foucault men-
tions in his Lectures at the Colle`ge de France, the
treatment that SAs face is not necessarily due to ma-
licious intent; rather, any observed effects are simply
the outcomes of the relationship of power structures
to their object (Foucault 28). In this paper, I use a
Foucauldian analysis to argue that Bedi’s story illus-
trates a much a larger trend: disciplinary and reg-
ulatory mechanisms in medical practice, guidelines,
and funding normalize the Caucasian body as ‘the
body’ in Western medical best practices. Individu-
als and institutions are bound by discursive webs of
power that are often unnoticed by the subjects who
perpetuate them (Razack et al.). A Foucauldian anal-
ysis renders these power relations visible, thereby ex-
posing the norms that make live certain populations
while others are let die.
Examining the SA population through a Fou-
cauldian lens begins with the empirical mapping of
histories (Foucault 66), which in this case is the
heightened CVD risk faced by SAs. The mechanisms
of disciplinary power, used to enforce social cohesion
through surveillance (33), are made manifest by ex-
amining power in its most dilute and regional institu-
tions (27). In each instance, the State fashions itself
a series of norms that codifies and stratifies society,
making subgroups like SAs legible to power (255).
These norms are enacted by doctors and included
in guidelines, shored up through claims of “scien-
tificity,” subjugating other knowledges that vary from
the norm (7-8). In examining how this ‘science of sub-
jugation’ is funded, the biopolitical control of popu-
lations is made apparent through the racist dialogue
that thrums beneath the veneer of an “equal” soci-
ety (245). Thus, the presupposition of the Caucasian
body as the norm in medical best practices “makes
live” whiteness and “lets die” South Asian popula-
tions.
This essay is limited by the scarcity of Canadian-
focused primary research in South Asian populations.
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This, in and of itself, is a mark of the indifference of
the State toward SAs. As a result, it is necessary
to use American research to supplement Canadian
literature. Therefore, it is also important to mention
the similarities and differences between Canadian and
American SA populations. One important similarity
is that, regardless of location, the physiology of SAs
is unlikely to change based on geography (Anand).
Key among the differences is the contrasting poli-
cies concerning cultural identity: Canada has a mul-
ticultural ‘mosaic’ policy approach, while the U.S.
has an assimilation-based ‘Melting Pot’ perspective
(Peach 7-8). These differences in policy surrounding
cultural practices may affect any discussion of top-
ics that are culturally specific, including the cultural
sensitivity in treatment plans and patient-physician
interactions.
As Foucault does in his lectures, this essay must
first empirically map the relations of subjugation; in
doing so, the ways in which SAs are manufactured
and constituted by their relationship to power comes
to light (45). The 2017 Canadian Cardiovascular So-
ciety HF guideline outlined many risk factors of CVD
including: diabetes, obesity, dyslipidemia, diet, and
sedentary behavior (Ezekowitz et al. 1344). Though
there is a scarcity of large-scale randomized clinical
trials (RCTs) and data pertaining to SAs (Fernando
et al. 1139), recent publications have begun to outline
the specific physiological ways in which the SA pop-
ulation is particularly susceptible to CVD (Rana et
al. E183). The “thrifty gene” hypothesis is a popular
genetic theory to explain elevated SA CVD risk; how-
ever, research to date is inconclusive regarding broad
genetic patterns that might suggest a hereditary pre-
disposition to disease (1144). That being said, most
of the increased CVD burden in SAs can be explained
by elevated traditional risk factors: and though they
are not shored up by genetics, there are still crucially
important differences between SAs and other groups.
One major risk factor that is highly prevalent within
SAs is type 2 diabetes mellitus (T2DM). Patients
with T2DM have been shown to have a 2 to 3 times
higher risk of cardiovascular death (Volgman et al.
e6). Not only do SAs have a 2 to 5-fold higher preva-
lence of T2DM than Caucasians or other ethnicities
(e6; Fernando et al. 1142), but they also receive diag-
noses up to 10 years earlier (Lau 102). This evidence
was corroborated in a longitudinal study conducted
between 2001 and 2012 in Ontario, Canada (Chiu et
al. 2), and was paralleled in South Asian immigrants
to Canada (Banerjee and Shah 2).
T2DM is also related to metabolic syndrome
(MetS), which is a cluster of insulin resistance-linked
factors including obesity and dyslipidemia. Obesity
is usually measured using Body Mass Index (BMI),
with a diagnostic cutoff of ≥ 25kg/m2 (Araneta et
al. 814). However, this cutoff is inappropriate for SA
populations, who have been shown to develop risk
factors and metabolic abnormalities at BMIs as low
as 21.0kg/m2, which compares to a BMI of 30kg/m2
in Caucasians. (Fernando et al. 1143). Further-
more, due to higher body fat percentages and abdom-
inal fat retention, the association between BMI and
CVD risk could be underestimated (Volgman et al.
e6; Fernando et al. 1143). Thus, current screening
standards for BMI both overlook many at-risk SA pa-
tients and underestimate CVD risk at each BMI level.
Dyslipidemia is another important risk factor, char-
acterized by abnormal cholesterol and triglyceride
levels in the blood (Volgman et al. e7). SAs have
consistently been shown to have low high-density
lipoprotein (HDL) cholesterol, elevated low-density
lipoprotein (LDL) cholesterol, hypertriglyceridemia
(higher concentration of blood triglycerides), all of
which could be pathophysiologically linked with in-
sulin resistance and MetS (Fernando et al. 1143).
Finally, two modifiable, but important, risk fac-
tors in SAs are diet and sedentary behaviour. The
SA diet is typically higher in carbohydrates and sat-
urated fats, which are both associated with higher
risk of dyslipidemia (Rana et al. E183). SAs are also
less active than other groups (E183). This could ac-
count for up to 20% of the excess CHD risk in SAs,
potentially through heightened risk for obesity and
T2DM (Fernando et al. 1144). Ultimately, medical
research to date has provided strong evidence to sup-
port a unique CVD risk profile for SAs. This suggests
that ‘equal’ treatment of all ethnic groups may not be
equitable, and providing the same drug and lifestyle
interventions may actually cause harm. It is clear
that in order for the SA body to live and thrive, the
development of patient-focused and culturally sensi-
tive interventions is necessary.
An ascending Foucauldian analysis of power be-
gins in the capillaries. By examining power in its
“most regional forms and institutions,” it is possi-
ble to discern where broader power intervenes in the
lives of citizens (Foucault 27). In these regional in-
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stitutions, power is expressed through “mechanisms
of disciplinary coercion,” exercised through “constant
surveillance” that enforces the cohesion of the social
body (37; 33). To clarify, the executors of power
are not interested in the objects of their subjuga-
tion, but rather in the mechanisms of exclusion and
any economic or political profit reaped thereof (33).
These mechanisms set up the precondition of racism
and differential treatment that “makes killing accept-
able” (256). In medicine, the most capillary institu-
tions of power are the clinics, where patients, pri-
mary care physicians, and specialists interact daily.
In these spaces, doctors are the conduits for disci-
plinary power, and individuals are subject to intense
scrutiny. Using medicalized knowledge to connect
symptoms to disease states, doctors constitute their
patients by their deviation from the mean “healthy
body.” In an effort to “rehabilitate” the body back
towards the norm of productivity, they assign treat-
ments to resolve these variances (33). However, pa-
tients are also constituted by each other—physician
interactions with Caucasian patients provide them
with a ‘baseline’ against which they can compare
their ethnic patients (Johnson et al. 263). Hence,
through othering narratives and implicit bias, SA pa-
tients are further constituted not by their identity as
an individual patient, but through their differences
from Caucasian patients (263).
In a study done on care providers’ discussions
about SA patients, these narratives were glaringly ap-
parent and highly prevalent across providers (John-
son et al. 259). The racist practices were “radi-
cally heterogeneous” in their execution (Foucault 26),
but commonly utilized language that distinguished
“them [South Asians]” from “us [Caucasians],” and
enabled the separation of SAs as a group (Johnson et
al. 259; 263). For example, clinicians made particu-
lar reference to Caucasians as the compliant “ideal-
ized patient” who fit their clinical expectations (263),
and made condescending and racialized assumptions
about their non-ideal (i.e. SA) patients (264). These
prejudices can lead to very real actions: providers
have been shown to spend more time learning about
the needs of Caucasian patients while ethnic minori-
ties are pushed aside (Hall et al. e61). Worse, the ig-
norance of physicians regarding the unique SA CVD
risk profile puts patients at risk and diverts them
from care: physician use of BMI in SA risk assessment
means that some patients are overlooked (Araneta
et al. 814); implicit biases result in lower cardiac
rehabilitation recommendation rates (Mochari et al.
10); and the lack of culturally sensitive cardiac re-
habilitation programs present a barrier to SA access
and adherence to treatment (Banerjee et al. 215-
16). As a direct result, the Caucasian population
reaps the “economic profit” produced by these disci-
plinary mechanisms (Foucault 33). Not only do they
receive more comprehensive treatment (as a function
of increased facetime), but in a health system that is
resource-strapped, every time a SA is diverted from
care, those resources are necessarily given to another.
In this way, the healthcare system also has a racist ef-
fect in that it has determined that Caucasian bodies
are to be made live and South Asian bodies are to be
let die. This serves to “justif[y] the death-function”
of biopower—it appeals to the principle that, given fi-
nite resources, the death of SA patients means better
prospects for others (258).
While disciplinary power operates on the level of
man-as-body, other power mechanisms are needed to
control the general population (Foucault 242). This
new phenomenon, “biopower,” introduced mecha-
nisms, including forecasts and statistics, that con-
trolled the biological processes of man-as-species
rather than identifying and modifying individuals
(247). These functions intervened at the broadest
level to influence the generality of population statis-
tics by promoting certain norms of bodily conduct
(246). Importantly, they attempted to establish an
“average” for the population, compensating for the
natural variation within the State in order to “op-
timize a state of life” and achieve social control
(246). Thus, these functions make claims to univer-
sality while they are, in fact, particular (65). Yet,
these claims to generality are the main expression
of power, shored up through claims to scientificity
(7). Medicine, in particular, has a stake in proclaim-
ing its “scientificity,” casting aside other knowledges
that do not fit the norm through so-called ‘justified
principles’ (7). The localized knowledge of the pa-
tient or the doctor are dismissed as “insufficiently
elaborated” and become subjugated (8). The life of
medicine as a discipline is in claiming these gener-
alities, and moreover, claiming their application to
localized instances. Medical school trains doctors in
these medical generalizations; clinical practice guide-
lines (CPGs) provide ‘gold standard’ and ‘evidence-
based’ generalized recommendations for practitioners
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(Canadian Cardiovascular Society).
Despite established risk factors, there is a paucity
of SA-specific recommendations in Canadian heart
CPGs. The guidelines for ischemic heart disease,
systematizing inpatient referrals to cardiac rehabil-
itation, and pulmonary arterial hypertension make
no mention of any differences for SA populations
(Mancini et al.; Grace et al.; Langleben et al.).
The 2016 update for lipid CPGs include a con-
sideration for earlier screening in SAs, though the
recommended screening methods are “not validated
for South Asian[s],” (Anderson et al. 1266; 1265).
These findings are startling, especially considering
the wealth of recent reviews and studies that sup-
port a distinct SA risk profile. An explanation can
be found by examining the evidence that CPGs are
founded on. CPGs are themselves robust reviews
of the literature and provide recommendations with
varying degrees of confidence (Canadian Cardiovas-
cular Society). The gold standard sources of evi-
dence for strong recommendations are large, multi-
center RCTs. However, as previously indicated, there
is a lack of large-scale RCTs for SA populations (Fer-
nando et al. 1139). As a result, findings from smaller
studies become subjugated, as they do not provide
high enough quality evidence; they are “below the re-
quired level of erudition” (Foucault 6). This dearth
can be partially explained due to a lack of fund-
ing. RCTs are expensive to run, and researchers rely
on government grants for capital—it is here where
racism intervenes. In choosing what research is to
be provided with a grant, government agencies de-
termine which bodies are worth studying, creating
caesuras among the biological continuum (255). This
is how the medicalized “letting die” of SAs begins,
with the relative indifference of the medical field to
the increased CVD burden in SAs.
A U.S.-based article documented systemic racism
in healthcare, showing that powerful decision-makers
have historically been white, a pattern that persists
today (Feagin and Bennefield 8). Research-funding
institutions are racialized and largely white-oriented;
as a direct result, research efforts to investigate health
disparities are largely underfunded (9). These trends
are also highly prevalent in Canada. For example,
Dr. Sonia Anand is a world-renowned researcher in
Ethnic Diversity and CVD. Yet when she began her
research more than 20 years ago, it took multiple
grant applications to receive funding to study CVD
in SAs. At the time, the government agency peer re-
view committee was hesitant to provide funding to
research SAs, who were deemed to be “not as im-
portant” as other research in mainstream Canadians
(Anand). In other words, the agency was unwilling
to fund research for non-white bodies.
Though there have been recent efforts to docu-
ment the CVD burden in SAs (e.g. the MASALA
study), these RCTs are still in their infancy and are
located in the U.S. (Volgman et al. e5). Hence,
guidelines are forced to utilize previously published
RCTs, where South Asians are underrepresented
among study cohorts (Quay et al. 1). It is impor-
tant to note that some of the relevant barriers in-
cluded cultural insensitivity, a lack of effort on the
behalf of researchers to recruit diverse cohorts, and
researcher bias (8). A UK study noted that affa-
ble patients are often “cherry picked,” for research
(Hussain-Gambles et al. 157). Most often, these
“idealized patients” are also Caucasian (Johnson et
al. 263; Anand). While this study was conducted
in the UK, it is likely that these attitudes are also
present in Canada (Anand). Hence, CPGs based on
these RCTs act much like the unjust kings of Ro-
man history: they are partisan, but they speak as if
they are not (Foucault 72). The recommendations
do not, in fact, apply to all populations, for they are
based on research conducted upon the white man’s
body. Recently, efforts have been made to rectify
this issue and improve diversity in both cardiovas-
cular clinical trials and medicine as a whole (Ortega
et al.). Yet underrepresentation of people of color,
women, and other traditionally marginalized groups
remains a persistent issue (Grumbach and Mendoza).
These efforts are necessary, and must be intensified
to achieve better diversity in the future, but there is
significant work that remains before we achieve that
goal. Fundamentally, biopower has intervened on the
level of population dynamics, and has contributed
to the creation of a normalized society, which is the
“precondition” to the letting die of those outside the
norm (Foucault 256). In this way, the ‘white body’
became ‘the body’ in medical practice, and the roots
of these generalities have long since been forgotten.
It is also important to comment on how this essay
fits into a much broader context. Examining these
power relations and making their effects legible is,
in itself, a form of race struggle. Consequently, this
essay also contains a counterhistorical function (Fou-
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cault 66). In this essay, I have attempted to act as
a historian and cartographer, mapping the rituals of
power and how SAs are constituted by power (67).
This essay delineates the race struggle against white
hegemony in medicine, situated in a counterhistory
that was long-hidden in the “darkness and silence”
of subjugation (70). However, this essay is not only
a documentation or critique—it is also an “attack”
on power, and a “demand” (73). Within this essay
is a call to recognize the increased CVD burden in
SAs, and moreover, a call for a healthcare system
that is better equipped to treat the SA population.
Finally, it is important to recognize that while this
essay is specific to SAs, the medicalized letting die of
bodies is not. The biopolitical mechanisms in soci-
ety may operate in similar fashion for other groups,
such as those defined by the isms (e.g. women, in-
digenous peoples). Moreover, many members of the
SA population may possess intersectional identities
that contribute to unique forms of discrimination be-
yond those documented in this essay. While this es-
say was limited in scope to the ethnic identity of SAs,
these other aspects of identity are equally important.
These groups also demand recognition, especially in
the juridical form of the State (222).
Navdeep Bedi Singh’s case was tragic, but, luck-
ily, he recovered from his surgery. Many others are
not as lucky. Bedi’s case ultimately delineates the
larger issue of white hegemony in medicine. Though
it is clear that SAs pose a unique risk profile com-
pared to Caucasians, this is not recognized by health-
care professionals. Rather, they utilize their own pre-
suppositions to prejudicially [mis]treat SAs. While
physicians’ actions are rarely intentional, the con-
sequences are nonetheless real and highly prevalent.
CPGs dismiss existing literature about SAs as insuffi-
ciently erudite, and normalize population recommen-
dations based on research conducted with primarily
Caucasian cohorts. Ultimately, these power relation-
ships are structured and sponsored by the State when
its agencies decide which bodies are worthy of study.
These effects are not mutually exclusive; in fact, they
amplify each other and intensify the making live of
whiteness, and the letting die of SAs. Yet essays like
this one aspire to have a counterhistorical function,
and demand recognition of the SA body. As such,
it is my hope that by contributing to the larger dis-
course and rendering the SA counterhistory visible,
that this change will be forthcoming as the medical
community strides forward into the future.
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